KAYSHA SMITH: Open Payments
NPI 1295414464 · MANSFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 11 payments from 7 companies in 2025. Trend: 2023 $35 · 2024 $269 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $89 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Astellas Pharma US Inc | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
Products named: Rybelsus, Ozempic, Veozah, REXULTI, Dexcom G6 Transmitter, VIBERZI, GARDASIL 9, VAXELIS.
Industry payments across MO — which companies pay providers there.
